Leqembi approved for use in Australia
The Therapeutic Goods Administration has registered a new amyloid-lowering therapy for adult patients with mild cognitive impairment due to Alzheimer’s...
Lecanemab
New dementia drugs too costly, says clinician
The cost of a new wave of drugs to treat Alzheimer’s disease may be too prohibitive for many people living...